SCHEMBL965893

SCHEMBL965893

CCCCCCCCC(CCCCCC)CNCC(CCCCCC)CCCCCCCC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.65
ALDH1A1 P00352 3/20 0.65
CYP3A4 P08684 1/20 0.65
LMNA P02545 1/20 0.54
ADH1B P00325 1/20 0.45
ADH1C P00326 1/20 0.45
ADH1A P07327 1/20 0.45
ADH4 P08319 1/20 0.45
ADH7 P40394 1/20 0.45
THRB P10828 1/20 0.42
DNM1 Q05193 2/20 0.42
LCK P06239 1/20 0.41
PPARD Q03181 1/20 0.41
ZDHHC20 Q5W0Z9 1/20 0.41
ZDHHC2 Q9UIJ5 1/20 0.41
KDM4E B2RXH2 1/20 0.41
OPRM1 P35372 1/20 0.40
FDPS P14324 3/20 0.38
GPR84 Q9NQS5 2/20 0.38
SPHK1 Q9NYA1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL965573 1.00 TSHR (0.65) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL965056 1.00 TSHR (0.65) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL10411852 0.97 ALDH1A1 (0.70) TSHRALDH1A1CYP3A4LMNAADH1B
Hydrochloric Acid SCHEMBL9178593 0.97 TSHR (0.62) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL9361148 0.97 ALDH1A1 (0.70) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL16236848 0.95 ALDH1A1 (0.60) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL15057305 0.95 ALDH1A1 (0.60) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL16237314 0.95 ALDH1A1 (0.73) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL16236793 0.93 ALDH1A1 (0.64) TSHRALDH1A1CYP3A4LMNAADH1B
SCHEMBL277614 0.92 ALDH1A1 (0.62) TSHRALDH1A1CYP3A4LMNAADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583816-B2 Lipids for lipid nanoparticle delivery of active agents Acuitas Therapeutics, Inc. (CA) 2026-03-24 US disclosed
EP-3986993-B1 CONTINUOUS ACOUSTIC MIXING FOR PERFORMANCE ADDITIVES AND COMPOSITIONS INCLUDING THE SAME LUBRIZOL CORP (US) 2025-12-10 EP disclosed
EP-4655365-A1 LUBRICATING COMPOSITION WITH PHENOLIC ANTIOXIDANT AND LOW ACTIVE SULFUR The Lubrizol Corporation (US) 2025-12-03 EP disclosed
EP-4077601-B1 POLYMERIC SURFACTANT COMPOUND LUBRIZOL CORP (US) 2025-09-24 EP disclosed
WO-2025024623-A1 LUBRICATING COMPOSITION WITH PHENOLIC ANTIOXIDANT, CALCIUM SALICYLATE DETERGENT, AND LOW ACTIVE SULFUR THE LUBRIZOL CORPORATION (US) 2025-01-30 WO disclosed
EP-4481020-A2 POLYISOBUTYLENE-SUBSTITUTED PHENOL, DERIVATIVES THEREOF, AND LUBRICATING COMPOSITIONS CONTAINING THE POLYISOBUTYLENESUBSTITUTED PHENOL AND ITS DERIVATIVES The Lubrizol Corporation (US) 2024-12-25 EP disclosed
EP-3510130-B1 TOTAL BASE NUMBER BOOSTERS FOR MARINE DIESEL ENGINE LUBRICATING COMPOSITIONS LUBRIZOL CORP (US) 2024-12-18 EP disclosed
EP-3390591-B1 LUBRICATING COMPOSITIONS COMPRISING SULFURIZED CATECHOLATE DETERGENTS LUBRIZOL CORP (US) 2024-10-30 EP disclosed
US-12098345-B2 Polymeric surfactant compound THE LUBRIZOL CORPORATION (US) 2024-09-24 US disclosed
EP-3472274-B1 LUBRICATING COMPOSITIONS CONTAINING A POLYISOBUTYLENE-SUBSTITUTED PHENOL LUBRIZOL CORP (US) 2024-08-07 EP disclosed
EP-2650121-A1 GAS-BARRIER FILM, METHOD FOR PRODUCING GAS-BARRIER FILM, AND ELECTRONIC DEVICE Konica Minolta, Inc. (JP) 2013-10-16 EP disclosed
US-20130236710-A1 GAS-BARRIER FILM, METHOD FOR PRODUCING GAS-BARRIER FILM, AND ELECTRONIC DEVICE KONICA MINOLTA , INC. (JP) 2013-09-12 US disclosed
EP-2280057-B1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE IDEMITSU KOSAN CO (JP) 2013-09-11 EP disclosed
EP-2280057-A1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE Idemitsu Kosan Co., Ltd. (JP) 2011-02-02 EP disclosed
US-20110021393-A1 LUBRICATING OIL COMPOSITION FOR INTERNAL COMBUSTION ENGINE IDEMITSU KOSAN CO., LTD. (JP) 2011-01-27 US disclosed
US-7820599-B2 Lubricating oil composition IDEMITSU KOSAN CO., LTD. (JP) 2010-10-26 US disclosed
US-20090082233-A1 LUBRICATING OIL COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2009-03-26 US disclosed
EP-1088882-B1 Lubricating compositions comprising a molybdenum-containing amine compound ASAHI DENKA KOGYO KK (JP) 2004-12-15 EP disclosed
US-6329327-B1 MOLYBDENUM AMINE COMPOUND FORMED BY REACTION OF HEXAVALENT MOLYBDENUM WITH AMINE ASAHI DENKA KOGYO, K.K. (JP) 2001-12-11 US disclosed
EP-1088882-A1 Lubricating compositions comprising a molybdenum-containing amine compound ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2001-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583816-B2 Lipids for lipid nanoparticle delivery of active agents NPC1, LDLR, SGMS1 TSHR 2589/4885ALDH1A1 1473/4885CYP3A4 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.